Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
56,260,480
-
Total 13F shares
-
10,588,023
-
Share change
-
+1,595,826
-
Total reported value
-
$594,414,680
-
Price per share
-
$56.14
-
Number of holders
-
51
-
Value change
-
+$91,850,250
-
Number of buys
-
39
-
Number of sells
-
10
Institutional Holders of Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX) as of Q4 2019
As of 31 Dec 2019,
Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,588,023 shares.
The largest 10 holders included
EPIQ Capital Group, LLC, Capital Research Global Investors, SC US (TTGP), LTD., Capital International Investors, BlackRock Inc., Capital World Investors, VANGUARD GROUP INC, Alphabet Inc., STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.